Pharvaris (PHVS) Change in Account Payables (2020 - 2026)

Pharvaris (PHVS) reported Change in Account Payables of -$5.5 million for Q1 2026, down 1462.15% on a YoY basis from $406477.4 in Q1 2025, and down 1462.15% quarter-over-quarter from -$354436.7 in Q1 2025.

Pharvaris (PHVS) Change in Account Payables (2020 - 2026) Analysis & Trends

Pharvaris has reported Change in Account Payables for 6 years, with the latest figure at -$5.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Account Payables fell 1462.15% year-over-year to -$5.5 million; the trailing twelve-month figure through Mar 2026 stood at -$5.3 million (down 266.28% YoY), and the FY2025 full-year result was -$29272.3, down 101.64% from the prior year.
  • Change in Account Payables for Q1 2026 stood at -$5.5 million, down from -$354436.7 in the prior quarter.
  • The five-year high for Change in Account Payables was $3.0 million in Q3 2022, with the low at -$5.5 million in Q1 2026.
  • Historically, Change in Account Payables has averaged -$73005.5 across 4 years, with a median of $879352.9 in 2022.
  • Annual changes were most pronounced in 2022 — Change in Account Payables surged 603.06% — and 2026, when it plunged 1462.15%.
  • Pharvaris' Change in Account Payables stood at -$713969.1 in 2022, then jumped by 282.77% to $1.3 million in 2023, then tumbled by 127.16% to -$354436.7 in 2025, then sank by 1462.15% to -$5.5 million in 2026.
  • The last three Change in Account Payables figures came in at -$5.5 million (Q1 2026), -$354436.7 (Q1 2025), and $1.3 million (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -3.26 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 35.60 Mn
9 Abivax 90.15 Bn 90.15 Bn - -9.42 Mn
10 Pharvaris 28.66 Bn 28.37 Bn - -5.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.54 Mn
Mar 31, 2026 -5.54 Mn
Mar 31, 2025 -354,436.67
Mar 31, 2025 -354,436.67
Mar 31, 2023 1.30 Mn
Mar 31, 2023 1.30 Mn
Dec 31, 2022 -713,969.11
Dec 31, 2022 -713,969.11
Sep 30, 2022 2.95 Mn
Sep 30, 2022 2.95 Mn
Jun 30, 2022 879,352.88
Jun 30, 2022 879,352.88
Mar 31, 2022 958,803.01
Mar 31, 2022 958,803.01
Dec 31, 2021 -1.21 Mn
Dec 31, 2021 -1.21 Mn
Sep 30, 2021 419,751.99
Sep 30, 2021 419,751.99
Jun 30, 2021 -1.36 Mn
Jun 30, 2021 -1.36 Mn